Skip to main content
Back
finqOS
Search a stock, list or screen
⌘K
Not investment advice
Read full disclaimer
GLUE
———
Overview
Company
Financials
Valuation
News
Ownership
Documents
GLUE: Monte Rosa Therapeutics, Inc. Stock Analysis | finqOS
GLUE
$8.64
−3.03%
Lists
Call GLUE
Monte Rosa Therapeutics
GLUE
Back
Lists
Call GLUE
$8.64
−$0.27 · −3.03%
Closed
Overview
Company
Financials
Valuation
News
Ownership
Documents
Down
40%
in three months and
1%
of the way up its 52-week range.
Call GLUE
Loading chart data...
Signal state